GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » Degree of Financial Leverage

Target Group (Target Group) Degree of Financial Leverage : 0.77 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Target Group Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Target Group's Degree of Financial Leverage for the quarter that ended in Mar. 2024 was 0.77. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Target Group's Degree of Financial Leverage or its related term are showing as below:

CBDY's Degree of Financial Leverage is ranked better than
63.65% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.97 vs CBDY: 0.77

Target Group Degree of Financial Leverage Historical Data

The historical data trend for Target Group's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group Degree of Financial Leverage Chart

Target Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 1.71 0.71 -0.81 -

Target Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.48 2.08 -0.14 - 0.77

Competitive Comparison of Target Group's Degree of Financial Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Target Group's Degree of Financial Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Target Group's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Target Group's Degree of Financial Leverage falls into.



Target Group Degree of Financial Leverage Calculation

Target Group's Degree of Financial Leverage for the quarter that ended in Mar. 2024 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( 0.001 (Mar. 2024) / -0.008 (Mar. 2023) - 1 )/( 1.636 (Mar. 2024) / -3.519 (Mar. 2023) - 1 )
=-1.125/-1.4649
=0.77***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Target Group  (OTCPK:CBDY) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Target Group Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Target Group's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Target Group (Target Group) Business Description

Traded in Other Exchanges
N/A
Address
20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.
Executives
Barry Alan Katzman director 36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone director 564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte director 18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam director 42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali officer: CFO 134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr director, 10 percent owner, officer: President 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann director, 10 percent owner, officer: CEO 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust 10 percent owner 52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada) 10 percent owner 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr other: See Remarks 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy director, 10 percent owner, officer: president 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: vice president 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Target Group (Target Group) Headlines

From GuruFocus

Canary RX Receives its Health Canada Sales License

By PRNewswire PRNewswire 09-15-2021

Canary RX Announces Year to Date Wholesale Cannabis Sales

By PRNewswire PRNewswire 10-05-2021